Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
Monserrat Llaguno‐Munive(Instituto Nacional de Cancerología), Patricia García‐López(Instituto Nacional de Cancerología)
Cited by 25
Related Papers
Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment
|Pharmaceutics|2020|36
Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
|International Journal of Molecular Sciences|2022|17